FDA Inspection 1020668 — Covenant Medical Center

Covenant Medical Center — FEI 1671229

The FDA completed an inspection of Covenant Medical Center on March 6, 2017 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 6, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lubbock, TX (United States)